Literature DB >> 23486571

Effect of antibodies to glutamate on caspase-3 activity in brain structures of rats with experimental Alzheimer's disease.

V V Kolobov1, I A Zakharova, V G Fomina, V Yu Gorbatov, T V Davydova.   

Abstract

Experiments on rats have showed that neurodegenerative damage to the brain induced by injection of a neurotoxic β-amyloid protein fragment β25-35into the basal giant cell nuclei of Meynert activated caspase-3 in the prefrontal cortex and hippocampus on day 3 after injury. Intranasal administration of antibodies to glutamate in a dose of 300 μ g/kg 1 h after damage reduced enzyme activity in these structures in a rat model of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486571     DOI: 10.1007/s10517-013-1967-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

Review 1.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

2.  Caspase-3 is Involved in Aluminum-Induced Impairment of Long-Term Potentiation in Rats Through the Akt/GSK-3β Pathway.

Authors:  Huifang Zhang; Xiaojuan Yang; Xiujun Qin; Qiao Niu
Journal:  Neurotox Res       Date:  2016-01-19       Impact factor: 3.911

3.  Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.

Authors:  Mihir B Chauhan; Neelima B Chauhan
Journal:  J Neurol Neurosurg       Date:  2015

4.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.